Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2022). On theSindex it has a DataRank of 0.675. It has been cited 89 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.675
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K23 DK113220
National Institutes of Health
Grant: K01DK115525
National Institutes of Health
Grant: R01DK114326
NIDDK NIH HHS
Grant: R01 DK116878
BLRD VA
Grant: I01 BX004448
BLRD VA
Grant: IK6 BX005382
National Institutes of Health
Grant: 5R01DK116878-02
Hormonal Regulation of Liver Metabolism
National Institutes of Health
Grant: 5K01DK115525-02
Hepatocyte PPARgamma regulated mechanisms in NAFLD and lipid homeostasis
National Institutes of Health
Grant: 1K23DK113220-01
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
National Institutes of Health
Grant: 5I01BX004448-04
Hormonal control of NASH development and progression
National Institutes of Health
Grant: 5IK6BX005382-02
BLRD Research Career Scientist Award Application
FWCI
11.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals